The use of wearables for the diagnosis and treatment of Parkinson's disease

J Neural Transm (Vienna). 2023 Jun;130(6):783-791. doi: 10.1007/s00702-022-02575-5. Epub 2023 Jan 7.

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disorder, with increasing numbers of affected patients. Many patients lack adequate care due to insufficient specialist neurologists/geriatricians, and older patients experience difficulties traveling far distances to reach their treating physicians. A new option for these obstacles would be telemedicine and wearables. During the last decade, the development of wearable sensors has allowed for the continuous monitoring of bradykinesia and dyskinesia. Meanwhile, other systems can also detect tremors, freezing of gait, and gait problems. The most recently developed systems cover both sides of the body and include smartphone apps where the patients have to register their medication intake and well-being. In turn, the physicians receive advice on changing the patient's medication and recommendations for additional supportive therapies such as physiotherapy. The use of smartphone apps may also be adapted to detect PD symptoms such as bradykinesia, tremor, voice abnormalities, or changes in facial expression. Such tools can be used for the general population to detect PD early or for known PD patients to detect deterioration. It is noteworthy that most PD patients can use these digital tools. In modern times, wearable sensors and telemedicine open a new window of opportunity for patients with PD that are easy to use and accessible to most of the population.

Keywords: Digital medicine; Parkinson’s disease; Sensors; Telemedicine; Wearables.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Gait Disorders, Neurologic*
  • Humans
  • Hypokinesia / diagnosis
  • Parkinson Disease* / diagnosis
  • Parkinson Disease* / therapy
  • Tremor
  • Wearable Electronic Devices*